Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women

Milan M. Terzic, Jelena Dotlic, Sanja Maricic, Tihomir Mihailovic, Bratislava Tosic-Race

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Aim: Menopause is associated with adverse metabolic changes, especially in plasma lipoprotein and cholesterol levels. Estrogens have beneficial effects on lipid metabolism. Phytoestrogens are plant substances that are structurally and functionally similar to 17β-estradiol and are capable of producing estrogenic effects. The goal of the present study was to estimate the effects of red clover-derived isoflavones on serum lipid levels in postmenopausal women. Methods: The study comprised 40 healthy postmenopausal women with an average age of 56 years. The women were divided into two groups: 22 were allocated to a red clover-derived isoflavone medication group, and 18 were allocated to a non-medication group. Total blood cholesterol, cholesterol fractions and triglycerides in the women of both groups were investigated before treatment and at 4-month intervals over the following 12 months. Results: Both total serum cholesterol and low-density lipoprotein (LDL) cholesterol levels, as well as triglyceride levels, were decreased significantly in the group receiving phytoestrogens. However, high-density lipoprotein (HDL) cholesterol showed a significant increase. Conclusion: Red clover phytoestrogen supplementation in postmenopausal women had favorable metabolic effects on serum lipids. Furthermore, red clover phytoestrogens have no side-effects and can be considered safe.

Original languageEnglish
Pages (from-to)1091-1095
Number of pages5
JournalJournal of Obstetrics and Gynaecology Research
Volume35
Issue number6
DOIs
Publication statusPublished - Dec 1 2009
Externally publishedYes

Fingerprint

Trifolium
Isoflavones
Phytoestrogens
Lipids
Serum
Cholesterol
Estrogens
Menopause
Lipid Metabolism
LDL Cholesterol
HDL Cholesterol
Estradiol
Triglycerides

Keywords

  • Phytoestrogen
  • Plasma lipid
  • Postmenopause
  • Red clover-derived isoflavone

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women. / Terzic, Milan M.; Dotlic, Jelena; Maricic, Sanja; Mihailovic, Tihomir; Tosic-Race, Bratislava.

In: Journal of Obstetrics and Gynaecology Research, Vol. 35, No. 6, 01.12.2009, p. 1091-1095.

Research output: Contribution to journalArticle

Terzic, Milan M. ; Dotlic, Jelena ; Maricic, Sanja ; Mihailovic, Tihomir ; Tosic-Race, Bratislava. / Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women. In: Journal of Obstetrics and Gynaecology Research. 2009 ; Vol. 35, No. 6. pp. 1091-1095.
@article{44cb419855594323bc800c5a01244935,
title = "Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women",
abstract = "Aim: Menopause is associated with adverse metabolic changes, especially in plasma lipoprotein and cholesterol levels. Estrogens have beneficial effects on lipid metabolism. Phytoestrogens are plant substances that are structurally and functionally similar to 17β-estradiol and are capable of producing estrogenic effects. The goal of the present study was to estimate the effects of red clover-derived isoflavones on serum lipid levels in postmenopausal women. Methods: The study comprised 40 healthy postmenopausal women with an average age of 56 years. The women were divided into two groups: 22 were allocated to a red clover-derived isoflavone medication group, and 18 were allocated to a non-medication group. Total blood cholesterol, cholesterol fractions and triglycerides in the women of both groups were investigated before treatment and at 4-month intervals over the following 12 months. Results: Both total serum cholesterol and low-density lipoprotein (LDL) cholesterol levels, as well as triglyceride levels, were decreased significantly in the group receiving phytoestrogens. However, high-density lipoprotein (HDL) cholesterol showed a significant increase. Conclusion: Red clover phytoestrogen supplementation in postmenopausal women had favorable metabolic effects on serum lipids. Furthermore, red clover phytoestrogens have no side-effects and can be considered safe.",
keywords = "Phytoestrogen, Plasma lipid, Postmenopause, Red clover-derived isoflavone",
author = "Terzic, {Milan M.} and Jelena Dotlic and Sanja Maricic and Tihomir Mihailovic and Bratislava Tosic-Race",
year = "2009",
month = "12",
day = "1",
doi = "10.1111/j.1447-0756.2009.001059.x",
language = "English",
volume = "35",
pages = "1091--1095",
journal = "Journal of Obstetrics and Gynaecology Research",
issn = "1341-8076",
publisher = "Blackwell Publishing Asia",
number = "6",

}

TY - JOUR

T1 - Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women

AU - Terzic, Milan M.

AU - Dotlic, Jelena

AU - Maricic, Sanja

AU - Mihailovic, Tihomir

AU - Tosic-Race, Bratislava

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Aim: Menopause is associated with adverse metabolic changes, especially in plasma lipoprotein and cholesterol levels. Estrogens have beneficial effects on lipid metabolism. Phytoestrogens are plant substances that are structurally and functionally similar to 17β-estradiol and are capable of producing estrogenic effects. The goal of the present study was to estimate the effects of red clover-derived isoflavones on serum lipid levels in postmenopausal women. Methods: The study comprised 40 healthy postmenopausal women with an average age of 56 years. The women were divided into two groups: 22 were allocated to a red clover-derived isoflavone medication group, and 18 were allocated to a non-medication group. Total blood cholesterol, cholesterol fractions and triglycerides in the women of both groups were investigated before treatment and at 4-month intervals over the following 12 months. Results: Both total serum cholesterol and low-density lipoprotein (LDL) cholesterol levels, as well as triglyceride levels, were decreased significantly in the group receiving phytoestrogens. However, high-density lipoprotein (HDL) cholesterol showed a significant increase. Conclusion: Red clover phytoestrogen supplementation in postmenopausal women had favorable metabolic effects on serum lipids. Furthermore, red clover phytoestrogens have no side-effects and can be considered safe.

AB - Aim: Menopause is associated with adverse metabolic changes, especially in plasma lipoprotein and cholesterol levels. Estrogens have beneficial effects on lipid metabolism. Phytoestrogens are plant substances that are structurally and functionally similar to 17β-estradiol and are capable of producing estrogenic effects. The goal of the present study was to estimate the effects of red clover-derived isoflavones on serum lipid levels in postmenopausal women. Methods: The study comprised 40 healthy postmenopausal women with an average age of 56 years. The women were divided into two groups: 22 were allocated to a red clover-derived isoflavone medication group, and 18 were allocated to a non-medication group. Total blood cholesterol, cholesterol fractions and triglycerides in the women of both groups were investigated before treatment and at 4-month intervals over the following 12 months. Results: Both total serum cholesterol and low-density lipoprotein (LDL) cholesterol levels, as well as triglyceride levels, were decreased significantly in the group receiving phytoestrogens. However, high-density lipoprotein (HDL) cholesterol showed a significant increase. Conclusion: Red clover phytoestrogen supplementation in postmenopausal women had favorable metabolic effects on serum lipids. Furthermore, red clover phytoestrogens have no side-effects and can be considered safe.

KW - Phytoestrogen

KW - Plasma lipid

KW - Postmenopause

KW - Red clover-derived isoflavone

UR - http://www.scopus.com/inward/record.url?scp=71149087268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71149087268&partnerID=8YFLogxK

U2 - 10.1111/j.1447-0756.2009.001059.x

DO - 10.1111/j.1447-0756.2009.001059.x

M3 - Article

VL - 35

SP - 1091

EP - 1095

JO - Journal of Obstetrics and Gynaecology Research

JF - Journal of Obstetrics and Gynaecology Research

SN - 1341-8076

IS - 6

ER -